-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Solid Biosciences Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2023.
- Solid Biosciences Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.46M, a 15.1% increase year-over-year.
- Solid Biosciences Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $9.66M, a 62.4% decline year-over-year.
- Solid Biosciences Inc. annual Nonoperating Income (Expense) for 2023 was $8.24M, a 59.8% decline from 2022.
- Solid Biosciences Inc. annual Nonoperating Income (Expense) for 2022 was $20.5M, a 30917% increase from 2021.
- Solid Biosciences Inc. annual Nonoperating Income (Expense) for 2021 was $66K, a 43.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)